| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
andrew_hill [2022/01/04 16:56]
brian | andrew_hill [2022/04/07 10:17] (current)
mathew |
|---|
| |
| ==== Pandemic Research ==== | ==== Pandemic Research ==== |
| [[https://www.researchgate.net/publication/357137229_Minimum_manufacturing_costs_national_prices_and_estimated_global_availability_of_new_repurposed_therapies_for_COVID-19|Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19]] | [[https://www.researchgate.net/publication/357137229_Minimum_manufacturing_costs_national_prices_and_estimated_global_availability_of_new_repurposed_therapies_for_COVID-19|Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19]] \\ |
| [[https://www.researchgate.net/publication/356795957_529_Systematic_Review_and_Meta-Analysis_of_Ivermectin_Safety_Profile_in_COVID-19_Trials|Systematic Review and Meta-Analysis of Ivermectin Safety Profile in COVID-19 Trials]] | [[https://www.researchgate.net/publication/356795957_529_Systematic_Review_and_Meta-Analysis_of_Ivermectin_Safety_Profile_in_COVID-19_Trials|Systematic Review and Meta-Analysis of Ivermectin Safety Profile in COVID-19 Trials]] \\ |
| [[https://www.researchgate.net/publication/356399920_Ivermectin_for_the_prevention_of_COVID-19_addressing_potential_bias_and_medical_fraud|Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud]] | [[https://www.researchgate.net/publication/356399920_Ivermectin_for_the_prevention_of_COVID-19_addressing_potential_bias_and_medical_fraud|Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud]] \\ |
| [[https://www.researchgate.net/publication/353786495_Expression_of_Concern_Meta-analysis_of_Randomized_Trials_of_Ivermectin_to_Treat_SARS-CoV-2_Infection|Expression of Concern: “Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection”]] | [[https://www.researchgate.net/publication/353786495_Expression_of_Concern_Meta-analysis_of_Randomized_Trials_of_Ivermectin_to_Treat_SARS-CoV-2_Infection|Expression of Concern: “Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection”]] \\ |
| | [[https://academic.oup.com/ofid/article/8/11/ofab358/6316214|Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection]] |
| |
| === Ivermectin Efficacy === | === Ivermectin Efficacy === |
| https://c19ivermectin.com/hill.html | https://c19ivermectin.com/hill.html |
| | |
| | === MOVe-OUT Clinical Trial === |
| | A paper authored by [[:Kristian Thorlund]], [[:Kyle Sheldrick]], [[:Gideon Meyerowitz-Katz]], [[:Sonal Singh]], and Hill critiqued the MOVe-OUT clinical trial studying [[molnupiravir]].((March 11, 2022 | [[:Kristian Thorlund]] et al | American Journal of Tropical Medicine and Hygiene | Making Statistical Sense of the Molnupiravir MOVe-OUT Clinical Trial | [[https://pubmed.ncbi.nlm.nih.gov/35276667/|doi: 10.4269/ajtmh.21-1339]])) |
| |
| === Presentations === | === Presentations === |
| [[https://youtu.be/eu61dtsSLrk|Ivermectin meta-analysis]] by Dr. Andrew Hill EXTENDED Jan 20, 2021 | [[https://youtu.be/eu61dtsSLrk|Ivermectin meta-analysis]] by Dr. Andrew Hill EXTENDED Jan 20, 2021 |
